Evidence map›Paper›PMID 36980297›Full record

ReviewCells2023

Brain Vascular Health in ALS Is Mediated through Motor Cortex Microvascular Integrity.

Stefanie Schreiber, Jose Bernal, Philipp Arndt, Frank Schreiber, Patrick Müller, Lorena Morton, Rüdiger Christian Braun-Dullaeus, Maria Del Carmen Valdés-Hernández, Roberto Duarte, Joanna Marguerite Wardlaw and 7 more

Open access · goldFull text readReview
In one paragraph

Review in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. DRIPS: Domain Randomisation for Image-based Perivascular spaces Segmentation.medRxiv : the preprint server for health sciences · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 2 countries.

Stefanie SchreiberDepartment of Neurology, Otto von Guericke University Magdeburg, Medical Faculty, 39120 Magdeburg, Germany.ORCID 0000-0003-4439-4374
Jose BernalDepartment of Neurology, Otto von Guericke University Magdeburg, Medical Faculty, 39120 Magdeburg, Germany.ORCID 0000-0003-3167-5134
Philipp ArndtDepartment of Neurology, Otto von Guericke University Magdeburg, Medical Faculty, 39120 Magdeburg, Germany.ORCID 0000-0002-0517-6473
Frank SchreiberDepartment of Neurology, Otto von Guericke University Magdeburg, Medical Faculty, 39120 Magdeburg, Germany.ORCID 0000-0002-9484-8613
Patrick MüllerGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.
Lorena MortonInstitute of Inflammation and Neurodegeneration, Otto von Guericke University Magdeburg, 39120 Magdeburg, Germany.ORCID 0000-0002-3957-3848
Rüdiger Christian Braun-DullaeusDepartment of Internal Medicine/Cardiology and Angiology, Otto von Guericke University Magdeburg, 39120 Magdeburg, Germany.
Maria Del Carmen Valdés-HernándezCentre for Clinical Brain Sciences, The University of Edinburgh, UK Dementia Research Institute Centre, Edinburgh EH16 4UX, UK.ORCID 0000-0003-2771-6546
Roberto DuarteCentre for Clinical Brain Sciences, The University of Edinburgh, UK Dementia Research Institute Centre, Edinburgh EH16 4UX, UK.
Joanna Marguerite WardlawCentre for Clinical Brain Sciences, The University of Edinburgh, UK Dementia Research Institute Centre, Edinburgh EH16 4UX, UK.ORCID 0000-0002-9812-6642
Sven Günther MeuthDepartment of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Grazia MietznerDepartment of Neurology, Otto von Guericke University Magdeburg, Medical Faculty, 39120 Magdeburg, Germany.
Stefan VielhaberDepartment of Neurology, Otto von Guericke University Magdeburg, Medical Faculty, 39120 Magdeburg, Germany.
Ildiko Rita DunayCenter for Behavioral Brain Sciences (CBBS), 39106 Magdeburg, Germany.
Alexander DityatevGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.ORCID 0000-0002-0472-0553
Solveig JandkeDepartment of Neurology, Otto von Guericke University Magdeburg, Medical Faculty, 39120 Magdeburg, Germany.ORCID 0000-0002-9103-7276
Hendrik MatternGerman Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, 39120 Magdeburg, Germany.ORCID 0000-0001-5740-4522
German Center for Neurodegenerative Diseases · DEOtto-von-Guericke-Universität Magdeburg · DEUK Dementia Research Institute · GBCenter for Behavioral Brain Sciences · DEHeinrich Heine University Düsseldorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain vascular health appears to be critical for preventing the development of amyotrophic lateral sclerosis (ALS) and slowing its progression. ALS patients often demonstrate cardiovascular risk factors and commonly suffer from cerebrovascular disease, with evidence of pathological alterations in their small cerebral blood vessels. Impaired vascular brain health has detrimental effects on motor neurons: vascular endothelial growth factor levels are lowered in ALS, which can compromise endothelial cell formation and the integrity of the blood-brain barrier. Increased turnover of neurovascular unit cells precedes their senescence, which, together with pericyte alterations, further fosters the failure of toxic metabolite removal. We here provide a comprehensive overview of the pathogenesis of impaired brain vascular health in ALS and how novel magnetic resonance imaging techniques can aid its detection. In particular, we discuss vascular patterns of blood supply to the motor cortex with the number of branches from the anterior and middle cerebral arteries acting as a novel marker of resistance and resilience against downstream effects of vascular risk and events in ALS. We outline how certain interventions adapted to patient needs and capabilities have the potential to mechanistically target the brain microvasculature towards favorable motor cortex blood supply patterns. Through this strategy, we aim to guide novel approaches to ALS management and a better understanding of ALS pathophysiology.

Indexed as

Amyotrophic Lateral SclerosisMotor CortexBlood-Brain BarrierHumansMotor NeuronsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Aamyotrophic lateral sclerosisexerkinesmotor cortexpericytesvascular supply

Identifiers

PMID36980297
PMCPMC10047140
OpenAlexW4353070495

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read20
identifiers read2
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.